Why Investors Shouldn't Be Surprised By Panacea Biotec Limited's (NSE:PANACEABIO) Low P/S
Apr 04
Indian (NIFTY) Biotech Industry Analysis
UpdatedMay 08, 2024
DataAggregated Company Financials
Companies9
- 7D-1.2%
- 3M1.3%
- 1Y18.7%
- YTD13.5%
Over the last 7 days, the Biotech industry has dropped 1.2%, driven by Zenotech Laboratories declining 8.6%. In the past year, the industry has gained 19%. As for the next few years, earnings are expected to grow by 8.7% per annum.
Industry Valuation and Performance
Has the Indian Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 09 May 2024 | ₹382.1b | ₹155.4b | ₹12.0b | 46.9x | 31.9x | 2.5x |
| Sat, 06 Apr 2024 | ₹354.0b | ₹155.4b | ₹12.0b | 38.5x | 29.5x | 2.3x |
| Mon, 04 Mar 2024 | ₹360.5b | ₹155.4b | ₹12.0b | 37.1x | 30x | 2.3x |
| Wed, 31 Jan 2024 | ₹342.2b | ₹145.0b | ₹5.3b | 56.5x | 64.9x | 2.4x |
| Fri, 29 Dec 2023 | ₹326.5b | ₹145.0b | ₹5.3b | 53.8x | 62.1x | 2.3x |
| Sun, 26 Nov 2023 | ₹311.5b | ₹145.0b | ₹5.3b | 53.6x | 59.3x | 2.1x |
| Tue, 24 Oct 2023 | ₹299.9b | ₹133.7b | ₹4.8b | 32.7x | 63.1x | 2.2x |
| Thu, 21 Sep 2023 | ₹356.6b | ₹133.8b | ₹4.8b | 29.8x | 74.6x | 2.7x |
| Sat, 19 Aug 2023 | ₹434.8b | ₹142.3b | ₹7.2b | 28.5x | 60.5x | 3.1x |
| Mon, 17 Jul 2023 | ₹340.8b | ₹120.4b | ₹4.5b | 41.8x | 75.6x | 2.8x |
| Wed, 14 Jun 2023 | ₹313.0b | ₹120.3b | ₹4.5b | 41.5x | 69.6x | 2.6x |
| Fri, 12 May 2023 | ₹325.0b | ₹106.7b | ₹16.2b | 28.2x | 20x | 3x |
| Sun, 09 Apr 2023 | ₹287.2b | ₹106.6b | ₹16.4b | 18.3x | 17.6x | 2.7x |
| Tue, 07 Mar 2023 | ₹301.1b | ₹106.5b | ₹16.3b | 32.5x | 18.4x | 2.8x |
| Thu, 02 Feb 2023 | ₹318.7b | ₹99.2b | ₹18.0b | 30.4x | 17.8x | 3.2x |
| Sat, 31 Dec 2022 | ₹347.0b | ₹99.2b | ₹18.0b | 33.5x | 19.3x | 3.5x |
| Mon, 28 Nov 2022 | ₹370.4b | ₹99.2b | ₹18.0b | 34.5x | 20.6x | 3.7x |
| Wed, 26 Oct 2022 | ₹360.2b | ₹95.5b | ₹18.2b | 31.2x | 19.8x | 3.8x |
| Fri, 23 Sep 2022 | ₹381.4b | ₹95.5b | ₹18.1b | 32.4x | 21x | 4x |
| Sun, 21 Aug 2022 | ₹405.1b | ₹95.5b | ₹18.2b | 33.9x | 22.3x | 4.2x |
| Tue, 19 Jul 2022 | ₹433.8b | ₹92.1b | ₹17.7b | 32.1x | 24.6x | 4.7x |
| Thu, 16 Jun 2022 | ₹425.9b | ₹92.1b | ₹17.7b | 31.6x | 24.1x | 4.6x |
| Sat, 14 May 2022 | ₹419.1b | ₹85.4b | ₹6.9b | 51.1x | 60.5x | 4.9x |
| Mon, 11 Apr 2022 | ₹458.6b | ₹79.4b | ₹7.0b | 58.4x | 65.1x | 5.8x |
| Wed, 09 Mar 2022 | ₹424.6b | ₹79.4b | ₹7.0b | 53.7x | 60.3x | 5.4x |
| Fri, 04 Feb 2022 | ₹504.3b | ₹79.4b | ₹7.0b | 66.6x | 71.6x | 6.4x |
| Sun, 02 Jan 2022 | ₹473.0b | ₹76.2b | ₹6.9b | 65.9x | 68.6x | 6.2x |
| Tue, 30 Nov 2021 | ₹467.3b | ₹76.2b | ₹6.9b | 56.2x | 67.8x | 6.1x |
| Thu, 28 Oct 2021 | ₹428.4b | ₹76.1b | ₹6.8b | 50.9x | 63.1x | 5.6x |
| Sat, 25 Sep 2021 | ₹455.6b | ₹75.2b | ₹7.1b | 62.5x | 64.4x | 6.1x |
| Mon, 23 Aug 2021 | ₹420.8b | ₹75.2b | ₹7.1b | 57.8x | 59.5x | 5.6x |
| Sat, 10 Jul 2021 | ₹509.2b | ₹75.2b | ₹7.1b | 70.2x | 72x | 6.8x |
Price to Earnings Ratio
64.5x
Current Industry PE
- Investors are pessimistic on the Indian Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 31.9x which is lower than its 3-year average PE of 47.7x.
- The 3-year average PS ratio of 4.1x is higher than the industry's current PS ratio of 2.5x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have grown 16% per year over the last three years.
- Revenues for these companies have grown 28% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Indian Healthcare industry?
| IN Market | -1.98% | |
| Healthcare | -1.06% | |
| Biotech | -1.22% | |
| Biotech | -1.22% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| BIOCON Biocon | ₹307.00 | 2.8% +₹10.1b | 24.5% | PE30.5x | |
| 524669 Hester Biosciences | ₹1.67k | 1.7% +₹234.8m | -6.4% | PE77.1x |